Results 11 to 20 of about 904 (106)

Ocular morbidity in children with allergic conjunctivitis: A rural-urban survey

Nigerian Journal of Medicine, 2023
Background: Allergic conjunctivitis occasionally may result in some ocular morbidities. This ranges from innocuous to severe forms of ocular disorders. Aim: This study reports and compares ocular morbidities among children with ocular allergies living in
Valerie Nawem Ihinose Abiola, Mary Ogbenyi Ugalahi, Eniola Olubukola Cadmus, Aderonke Mojisola Baiyeroju   +3 more
doaj   +1 more source

Apafant, a Potent Platelet-Activating Factor Antagonist, Blocks Eosinophil Activation and Is Effective in the Chronic Phase of Experimental Allergic Conjunctivitis in Guinea Pigs

Journal of Pharmacological Sciences, 2004
Platelet-activating factor (PAF) plays important roles in allergic reactions. In particular, there are many concerns about PAF, eosinophils, and the chronicity of allergic diseases.
Masatomo Kato, Kenji Imoto, Hideki Miyake, Tomoko Oda, Suguru Miyaji, Masatsugu Nakamura   +5 more
doaj   +1 more source

Current Knowledge in Allergic Conjunctivitis

Türk Oftalmoloji Dergisi, 2021
Allergic conjunctivitis is a disease of increasing prevalence that affects both children and adults and causes significant deterioration of their quality of life and sometimes irreversible visual damage.
Beatriz Vidal Villegas, Jose Manuel Benitez-del-Castillo   +1 more
doaj   +1 more source

Correlation between forkhead box P3 (rs3761548) gene polymorphism and serum interleukin13 as biomarkers of severity in Egyptian allergic conjunctivitis: a retrospective study

Frontiers in Allergy
IntroductionThe genetic variants that alter human Forkhead Box P3 (FOXP3) function may have a part in the establishment of allergic conjunctivitis. Our study aimed to evaluate the FOXP3 polymorphism, serum interleukin13 (IL13) and total immunoglobulin E (
Wesam A. Boghdady, Marwa A. Khairy, Ali G. Ali, Alia A. El Shahawy, Eman A. Abdelaziz, Aya A. El Shahawy, Fatma Z. Kamel   +6 more
doaj   +1 more source

Assessment of Quality of Life and Coexistent Allergic Conjunctivitis in Patients with Allergic Rhinitis in Van Province

Turkish Archives of Otorhinolaryngology, 2014
Objective:In this study, we aimed to evaluate coexistent allergic conjunctivitis with allergic rhinitis in Van province and the patients’ quality of life in this region.Methods:A total of 94 patients who were admitted to the Otorhinolaryngology Clinics ...
Ayfer Ulçay Belgü, Yusuf Orhan Uçal, Asiye Ekinci, Meryem Güler Alış, Ömürsen Yıldırım, Denizhan Dizdarorhanucal@gmail.com   +5 more
doaj   +1 more source

Expression of TSLP and Downstream Molecules IL-4, IL-5, and IL-13 on the Eye Surface of Patients with Various Types of Allergic Conjunctivitis

Journal of Ophthalmology, 2016
Background. The pathogenesis of allergic conjunctivitis has not been clearly established. Moreover, previous studies fail to consider human models of allergic conjunctivitis.
Xiaofen Zheng, Juan Yao, Bing Li
doaj   +1 more source

Observer-masked trial comparing efficacy of topical olopatadine (0.1%), bepotastine (1.5%), and alcaftadine (0.25%) in mild to moderate allergic conjunctivitis

Indian Journal of Ophthalmology, 2019
Purpose: With increasing environmental pollution, the incidence of allergic conjunctivitis is increasing. Newer anti-allergic medications with combined anti-histaminic and mast cell stabilization action can help reducing the use of topical steroids for ...
Lakshey Dudeja, Anuja Janakiraman, Ishani Dudeja, Kaustubh Sane, Manohar Babu   +4 more
doaj   +1 more source

IMMUNOPATHOLOGY OF ALLERGIC CONJUNCTIVITIS

European Medical Journal, 2020
Allergic conjunctivitis is predominantly an immunoglobulin E-mediated hypersensitivity reaction to environmental allergens. Allergic diseases affect >30% of the world’s population, of which 40% report associated ocular manifestations.
DeGaulle I. Chigbu, Bhawanjot K. Minhas
doaj  

Skin reactivity in allergic conjunctivitis

Revista Alergia México, 2018
Background: Allergic conjunctivitis is caused by an IgE-mediated mechanism or immediate hypersensitivity due to allergen direct contact on the conjunctival surface of sensitized patients, which elicits mastocyte activation and inflammatory mediators ...
Pablo Andrés Miranda-Machado, Bautista De la Cruz-Hoyos Sánchez   +1 more
doaj   +1 more source

A Randomized Phase II Study of Subcutaneous Mosunetuzumab in Combination With Polatuzumab Vedotin Compared With Rituximab Plus Polatuzumab Vedotin in Patients With Relapsed or Refractory Large B‐Cell Lymphoma

American Journal of Hematology, EarlyView.
ABSTRACT Mosunetuzumab plus polatuzumab vedotin has shown promising activity versus rituximab plus polatuzumab vedotin (R‐Pola) in patients with relapsed/refractory (R/R) large B‐cell lymphoma (LBCL; NCT03671018). We present results from the Phase II randomized cohort, evaluating subcutaneous mosunetuzumab plus polatuzumab vedotin (Mosun‐Pola), with ...
Julio C. Chavez, Mariana Bastos‐Oreiro, Catherine Diefenbach, Izidore S. Lossos, Nirav Shah, Sarit Assouline, Adam J. Olszewski, Seema Naik, Nilanjan Ghosh, Song Pham, Michael C. Wei, Connie Batlevi, Iris To, Wahib Ead, Sneha Makadia, Elicia Penuel, Jing Jing, Lihua E. Budde   +17 more
wiley   +1 more source